Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II randomized double-blind placebo- and active-controlled trial of MWN109 tablets in adults with type 2 diabetes mellitus
CTR20261918Phase 2Active
- Sponsor
- Shanghai Minwei Biotechnology Co., Ltd.
- Start
- May 2026
- Modality
- Peptides
- Countries
- 1
01
Overview
A Phase 2 trial of MWN109 in type 2 diabetes mellitus (T2DM), sponsored by Shanghai Minwei Biotechnology Co., Ltd.. Started May 2026; status: active.
02
Drugs
MWN109
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on CTR20261918.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20261918.